| Issue Date | Title | Author(s) |
| 2015 | Correction of adma-induced preeclampsia with the use of phosphodiesterase 5 and selective inhibitor of arginase II ZB49-0010 | Gureev, V. V.; Martynova, O. V.; Anciferova, O. E.; Martynov, M. A.; Pokrovskaia, T. G. |
| 2015 | Ion channel TRPA₁ is a promising therapeutic target for treatment of pain | Beskhmelnitsyna, E. A.; Korokin, M. V; Avtina, T. V.; Martynova, O. V.; Varavin, I. I.; Tishin, A. N. |
| 2019 | Neuroprotective effects of the novel ethylthiadiazole derivatives (LHT 4-15) in male rats | Martynov, M. A.; Cherevatenko, R. F.; Martynova, O. V.; Timokhina, A. S.; Ekimova, N. V. |
| 2020 | Non-hematopoietic erythropoietin-derived peptides for atheroprotection and treatment of cardiovascular diseases | Belyaeva, V. S.; Stepenko, Yu. V.; Kulikov, A. L.; Kochkarova, I. S.; Martynova, O. V.; Pokrovskiy, M. V. |
| 2015 | Simulation of total brain ischemia in rats | Martynova, O. V.; Gureev, V. V.; Pokrovskiy, M. V.; Martynov, M. A.; Solgalova, A. S. |
| 2017 | Tadalafil as an agent of pharmacological preconditioning in ischemic - reperfusion brain injury | Martynova, O. V. |
| 2016 | Thymosin β4 as basis for creation of a reparation preparation of new generation | Martynov, M. A.; Martynova, O. V.; Shkileva, I. Yu.; Tokarev, I. A.; Dovgan, A. N. |
